13G Filing: Balyasny Asset Management and Sunesis Pharmaceuticals Inc (SNSS)

Page 19 of 30

Page 19 of 30 – SEC Filing


(b) Percent of Class:
1.05%
(c) Number of Shares as to which person has:
(i) Sole power to vote or to direct vote:
224,506
(ii) Shared power to vote or to direct vote:
None
(iii) Sole power to dispose or direct disposition of:
224,506
(iv) Shared power to dispose or to direct disposition of:
None
AGI
(a) Amount Beneficially Owned:
By virtue of its ownership of 34.78% of the equity interest in AMF, AGI may be deemed to beneficially own the 224,506 Shares of the Companys Common Stock beneficially owned by AMF.
(b) Percent of Class:
1.05%
(c) Number of Shares as to which person has:
(i) Sole power to vote or to direct vote:
224,506
(ii) Shared power to vote or to direct vote:
None
(iii) Sole power to dispose or direct disposition of:
224,506

Page 19 of 30 Pages

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 19 of 30